F1RCR6 AF NFT

E3 ubiquitin-protein ligase TRIP12

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicffyydoqltcr2635ymf5q4ca5mm3kyl7xogru5qptsthmzolocqq/metadata.json
IPFS of structure file: 
bafybeibafgdbtqh4e7la2jpbmssz2xqud2cio4mcthus6u2fr5tsp4zgsm/AF-F1RCR6-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x01a12c15Eab6FFCFA8a2083d486B834c1B47E8c8
First NFT owner address (bech32): 
genesis1qxsjc902kmlul29zpq75s6urfsd506xg20duzx
Current NFT ID #473384 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
473384
Accession (UniProt):
F1RCR6
Name::
E3 ubiquitin-protein ligase TRIP12
Experimental Method:
Predicted structure
Sequence source:
DANIO RERIO

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT F1RCR6 research and analysis (ICN3D with VR)

FASTA sequences

>sp|F1RCR6|TRIPC_DANRE E3 ubiquitin-protein ligase TRIP12 OS=Danio rerio OX=7955 GN=trip12 PE=3 SV=1 MSNRPNSNPGGSLRRSQRNTAAAQPIDHTLAGRNSLSLSVGSLSIPDPDLEAAGTSGQQGRREGSSTRALKRSSVSEPNITFSPSPAKRPKVVSSHFSDSSASGPSAPAISPEVTEPRKAPASVSTKSKKRRLAAEPAPARALSKKSSSYPGPSGASSTPSQKRKKADATLLSSSSSSSLPSSSSAAGPLPPRSEASRAAKPTKLASKSAASAKAGCSTVTDSSSSSASSSSSSSSSSSAATGTNSCAPQGARLKQGKDQSKARRSRSASSPSPRRSSRDKEQSKAAGSSKFDWASRFNSKVNLPKPKLSLPGSAKAETSSKPGPSGLQAKLASLRKSTKKRSESPPAELPSCRRSTRQKTTGSCASTSRRGSGLGKRGAAEARRQEKMADSDNNQDGANSSAARTEETPQGASASSSVAGAVGMTTSGESESDDSEMGRLQALLEARGLPPHLFGPFGPRMSQLFHRTIGSGASSKAQQLLQGLQATGDESQQLQAAIEMCQLLVMGNEETLGGFPVKSVVPALITLLQMEHNFDIMNHASRALTYMMEALPRSSAVVVDAIPVFLEKLQVIQFIDVAEQALTALEMLSRRHSKAILQAGGLADCLLYLEFFSINAQRNALAIAANCCQSITPDEFHFVADSLPLLTQRLTHQDKKSVESTCLCFARLVDNFQHEENLLQQVASRDLLTNIQQLLVLTPPVLSSGMFIMVVRMFSLMCSNCPCLAVQLMKQNIAETLRFLLCGASNGSCQEQIDLVPRSPQELYELTSLICELMPCLPREGIFAVDAMLKKGSAQTTEGAIWQWRDDRGLWHPYNRIDSRIIEQINEDTGTARAIQRKPNPLANPNTGGHLEVRREDARAQLMKEDPELAKCFIKTLFGVLYEVYSSSAGPAVRHKCLRAILRIIYFADAELLKDVLRNHAVSSHIASMLSSQDLKIVVGSLQMAEILMQKLPDVFSVYFRREGVMHQVKNLAESEVFLTSPPKACTSGTASLCTTTITTATTTAASNVTPDLGSPSFQHSMDDSLDLSPQGRLSDVLKRKRLPKRGPRRPKYSPPRDDDKVDNQAKSPTTTQSPKSSFLASLNPKTWGKLGTQANSANSEPSRTAGVSGLARVPPKDSVSNNRDKIKAWIKEQASKFVERYFNSESVDGSNPALNVLQRLCTATEQLNLQMDSGVECLEEISSIVSESDVSSFEIQHSGLVKQLLLYLTSNSERDTISRDERIKRFLHVFFGCPIPGQEPPGRLDPTENGPLLALVHKMNNCLSQMEQFPVKVHDFPSGNGNGSRGSQALKFFNTHQLKCQLQRHPDCTNVKQWKGGPVKIDPLALVQAIERYLVVRGYGRIREEDEDSDDDGSDDEIDESLAAQFLNSGSVRHRLQFYIGEHLLPYNMTVYQAVRQFSLQAEEERESTDDEANPLGRAGIWTKTHTVWYKPVREDEEGCKDAVGGKRGRAQTAPTKTSPRNAKKQDELWHEGVCPSVANPLETYLICDPPEGITFDDPSMEVILLLRVLHSISRYWFYLYDNAACKEIIPTGEFINSKLTAKANRQLQDPLVIMTGNIPTWLTELGKTCPFFFPFDTRQMLFYVTAFDRDRAMQRLLDTNPEINQSDSQDSRVAPRLDRKKRTINRDELLKQAESVMQDLGSSRAMLEIQYENEVGTGLGPTQEFYALVSQELQRADLGLWRGEEVTLSNPKGSQEGTKYMFSSRGLFAVPFGRTTKPAHIAKIKMKFRFLGKLMAKAIMDFRLLDLPLGLPFYKWMLRHESSISSHDLVNIDPGVAKSIQHLEDIIRQKKRIEQDRSHTRETLQQALESLNMNGCSVEDLGLDFTLPGFPNIELKKGGKDVPVTIHNLEDYLRLVVYWTLNEGVLRQFESFREGFESVFPLHHLQYFYPEELDQLLCGSKSESWDVKTLMECCRPDHGYTHDSRAVRFLFEVLSSFDAEQQRLFLQFVTGSPRLPVGGFRSLNPPLTIVRKTFESTENPDDFLPSVMTCVNYLKLPDYSSIEIMREKLLIAAREGQQSFHLS